If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

William W. Ericson net worth and biography

William Ericson Biography and Net Worth

Director of Pacific Biosciences of California

William Ericson has been a member of our Board of Directors since 2004. Mr. Ericson is a Founding Partner at Wildcat Venture Partners where he focuses on investments in Digital Health. He is also a General Partner at Mohr Davidow Ventures (MDV) where he has led the firm’s focus on personalized medicine investing since 2003.

Mr. Ericson holds a B.S.F.S. from Georgetown University School of Foreign Service and a J.D. from Northwestern University School of Law. We believe that Mr. Ericson possesses specific attributes that qualify him to serve as a member of our Board of Directors, including his experience with multiple companies in the life sciences industry and his focus on companies with molecular diagnostic platforms that will enable the vision of personalized medicine.

What is William W. Ericson's net worth?: The estimated net worth of William W. Ericson is at least $168,027.30 as of March 15th, 2023. Mr. Ericson owns 18,795 shares of Pacific Biosciences of California stock worth more than $168,027 as of March 21st. This net worth approximation does not reflect any other investments that Mr. Ericson may own. Learn More about William W. Ericson's net worth.
How do I contact William W. Ericson?: The corporate mailing address for Mr. Ericson and other Pacific Biosciences of California executives is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. Pacific Biosciences of California can also be reached via phone at (650) 521-8000 and via email at [email protected] Learn More on William W. Ericson's contact information.
Has William W. Ericson been buying or selling shares of Pacific Biosciences of California?: Over the course of the past ninety days, William W. Ericson has sold $67,114.90 in shares of Pacific Biosciences of California stock. Most recently, William W. Ericson sold 7,541 shares of the business's stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $8.90, for a transaction totalling $67,114.90. Following the completion of the sale, the director now directly owns 18,795 shares of the company's stock, valued at $167,275.50. Learn More on William W. Ericson's trading history.
Who are Pacific Biosciences of California's active insiders?: Pacific Biosciences of California's insider roster includes (Pres), William Ericson (Director), Peter Fromen (Insider), Susan Kim (CFO), Kathy Ordonez (Director), and Mark Van Oene (COO). Learn More on Pacific Biosciences of California's active insiders.
Are insiders buying or selling shares of Pacific Biosciences of California?: During the last year, insiders at the biotechnology company sold shares 7 times. They sold a total of 189,490 shares worth more than $1,467,272.44. The most recent insider tranaction occured on March, 15th when Director William W Ericson sold 7,541 shares worth more than $67,114.90. Insiders at Pacific Biosciences of California own 1.4% of the company. Learn More about insider trades at Pacific Biosciences of California.
Information on this page was last updated on 3/15/2023.

William W. Ericson Insider Trading History at Pacific Biosciences of California

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2023	Sell	7,541	$8.90	$67,114.90	18,795
5/25/2021	Sell	37,500	$25.89	$970,875.00	12,500
8/19/2014	Buy	39,299	$5.14	$201,996.86
8/18/2014	Buy	135,155	$5.09	$687,938.95
8/14/2014	Buy	77,822	$5.00	$389,110.00
8/13/2014	Buy	29,435	$4.93	$145,114.55
8/12/2014	Buy	123,423	$4.89	$603,538.47

William W. Ericson Buying and Selling Activity at Pacific Biosciences of California

Pacific Biosciences of California Company Overview

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Today's Range

Now: $9.12

$8.47

$9.23

50 Day Range

MA: $10.18

$8.30

$12.02

2 Week Range

Now: $9.12

$3.85

$14.20

Volume

4,114,092 shs

Average Volume

4,397,261 shs

Market Capitalization

$2.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67

The Safest Option in Trades!

From Tradewins | Ad

Click here now!